The likelihood of participation in clinical trials can be measured: The Clinical Research Involvement Scales

Journal of Clinical Epidemiology

Volumn 63, Issue 10, 2010, Pages 1110-1117

  Frew, Paula M ^a,b,c,d   Hou, Su I ^e   Davis, Marsha ^e   Chan, Kayshin ^c   Horton, Takeia ^c   Shuster, Justin ^c   Hixson, Brooke ^c   Del Rio, Carlos ^a,b,c,d  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY CENTER FOR AIDS RESEARCH   (United States)

^c EMORY UNIVERSITY   (United States)

^d EMORY UNIVERSITY   (United States)

^e UNIVERSITY OF GEORGIA   (United States)

Author keywords

African Americans; HIV; HIV vaccines; Patient selection; Psychometrics; Recruitment; Women

Indexed keywords

ADULT; AGED; ARTICLE; ATTITUDE; BEHAVIOR; CLINICAL RESEARCH; CLINICAL RESEARCH INVOLVEMENT SCALE; COMPREHENSION; CONTENT VALIDITY; CONTROLLED STUDY; CRONBACH ALPHA COEFFICIENT; FACTORIAL ANALYSIS; FEMALE; HUMAN; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; PATIENT PARTICIPATION; PILOT STUDY; PRIORITY JOURNAL; QUESTIONNAIRE; RATING SCALE; RELIABILITY; SOCIAL SUPPORT; STATISTICAL MODEL; VALIDITY; ADOLESCENT; AFRICAN AMERICAN; ATTITUDE TO HEALTH; CLINICAL TRIAL; ETHNOLOGY; METHODOLOGY; MIDDLE AGED; PROBABILITY; PSYCHOLOGICAL ASPECT; PSYCHOMETRY; REPRODUCIBILITY; STATISTICS; UNITED STATES;

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ADOLESCENT; ADULT; AFRICAN AMERICANS; AIDS VACCINES; ATTITUDE TO HEALTH; CLINICAL TRIALS AS TOPIC; FACTOR ANALYSIS, STATISTICAL; FEMALE; GEORGIA; HUMANS; MALE; MIDDLE AGED; PATIENT PARTICIPATION; PROBABILITY; PSYCHOMETRICS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; YOUNG ADULT;

EID: 78349242159     PISSN: 08954356     EISSN: 18785921     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2009.12.002     Document Type: Article

References (57)

1. Nash D. Issuing an EDICT. Pharm Ther 2007;32:638-42.
2. Carter RE, Sonne SC, Brady KT. Practical considerations for estimating clinical trial accrual periods: application to a multi-center effectiveness study. BMC Med Res Methodol 2005;5:1-5.
3. Simon V. Wanted: women in clinical trials. Science 2005;308:1517.
4. Seto B. History of medical ethics and perspectives on disparities in minority recruitment and involvement in health research. Am J Med Sci 2001;322:246-50.
5. Comis RL, Miller JD, Aldige CR, Krebs L, Stoval E. Public attitudes toward participation in cancer clinical trials. J Clin Oncol 2003;21: 830-5.
6. Murthy V, Krumholz H, Gross C. Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA 2004;291:2720-6.
7. Curbow B, Fogarty LA, McDonnell KA, Chill J, Scott LB. The role of physician characteristics in clinical trial acceptance: testing pathways of influence. J Health Commun 2006;11:199-218.
8. Wendler D, Kington R,Madans J,WyeGV, Christ-Schmidt H, PrattLA, et al. Are racial and ethnic minorities less willing to participate in health research? PLoS Med 2006;3:-19.
9. Lovato LC, Hill K, Hertert S, Hunninghake DB, Probstfield JL. Recruitment for controlled clinical trials: literature summary and annotated bibliography. Control Clin Trials 1997;18:328-52.
10. Wood A, Grady C, Emanuel EJ. The crisis in human participants research: identifying the problems and proposing solutions.http://www.bioethics.gov/ emanuelpaper.html. Available at.
11. Opar A. New schemes aim to boost minority participation in research. Nat Med 2007;13:764-5.
12. National Institutes of Health. NIH Guidelines on the inclusion of women and minorities as subjects in clinical research. Bethesda, MD: National Institutes of Health; 1994.
13. Wermeling D, Selwitz A. Current issues surrounding women and minorities in drug trials. Ann Pharmacother 1993;27:904-11.
14. Baird K. The new NIH and FDA medical research policies: targeting gender, promoting justice. J Health Polit Policy Law 1999;24:531.
15. Haynes M, Smedley B, editors. The unequal burden of cancer: an assessment of NIH research and programs for ethnic minorities and the medically underserved. Washington, D.C.: National Academy Press; 1999.
16. Katz RV, Kegeles SS, Kressin NR, Green BL, Wang MQ, James SA, et al. The Tuskegee legacy project: willingness of minorities to participate in biomedical research. J Health Care Poor Underserved 2006;17: 698-715.
17. Sengupta S, Strauss RP, DeVellis R, Quinn SC, DeVellis B, Ware WB. Factors affecting African-American participation in AIDS research. J Acquir Immune Defic Syndr 2000;24:275-84.
18. Frew PM, Archibald M, Martinez N, del Rio C, Mulligan M. Promoting HIV vaccine research in the African American community: does the theory of reasoned action explain potential outcomes of involvement? Challenge J Morehouse Res Institute 2008;13:61-97.
19. Smith YR, Johnson AM, Newman LA, Greene A, Johnson TRB, Rogers JL. Perceptions of clinical research participation among African American women. J Women's Health 2007;16:423-505.
20. Gamble V. Under the shadow of Tuskegee: African Americans and health care. Am J Public Health 1997;87:1773-8.
21. Corbie-Smith G, Thomas SB,WilliamsMV, Moody-Ayers S. Attitudes and beliefs of African Americans toward participation in medical research. J Gen Intern Med 1999;14:537-46.
22. Bagozzi RP, Lee K, Van Loo MF. Decisions to donate bone marrow: the role of attitudes and subjective norms across cultures. Psychol Health 2001;16:29-56.
23. Davis C, Randhawa G. The influence of religion on organ donation and transplantation among the Black Caribbean and Black African populationda pilot study in the United Kingdom. Ethn Dis 2006;16:281-5.
24. Shavers-Hornaday VL, Lynch CF, Burmeister LF, Torner JC. Why are African Americans under-represented in medical research studies? Impediments to participation. Ethn Health 1997;2:31-45.
25. Khaliq W, Gross M, Thyagarajan B, Jones-Webb R. What motivates minorities to participate in research? Minn Med 2003;86:39-42.
26. SwansonGM,Ward AJ. Recruiting minorities into clinical trials: toward a participant-friendly system. J Natl Cancer Inst 1995;87:1747-59.
27. Frew PM, del Rio C, Clifton S, Archibald M, Hormes J, Mulligan MJ. Factors influencing HIV vaccine community engagement in the urban South. J Community Health 2008;33:259-69.
28. Gorelick PB, Richardson D, Hudson E, Perry C, Robinson D, Brown N, et al. Establishing a community network for recruitment of African Americans into a clinical trial. The African-American antiplatelet stroke prevention study (AAASPS) experience. J Natl Med Assoc 1996;88:701-4.
29. BeLue R, Taylor-Richardson KD, Lin J, Rivera AT, Grandison D. African Americans and participation in clinical trials: differences in beliefs and attitudes by gender. Contemp Clin Trials 2006;27: 498-505.
30. Frew PM, del Rio C, Lu L, Clifton S, Mulligan M. Understanding differences in enrollment in a Phase IIb HIV vaccine trial among high-risk populations. J Acquir Immune Defic Syndr 2009;50:314-9.
31. Djomand G, Katzman J, di Tommaso D, Hudgens MG, Counts GW, KoblinBA, et al. Enrollment of racial/ethnic minorities inNIAID-funded networks ofHIV vaccine trials in theUnited States, 1988 to 2002. Public Health Rep 2005;120:543-8.
32. Muhib F, Lin L, Stueve A, Miller R, FordW, JohnsonW, et al. Avenue-based method for sampling hard-to-reach populations. Public Health Rep 2001;116:216-22.
33. Frew PM, Crosby RA, Salazar LF, Gallinot L, Bryant LO, Holtgrave DR. Acceptance of an HIV/AIDS vaccine among minority women. J Natl Med Assoc 2008;100:802-13.
34. Fuchs J, Durham M, McLellan-Lemal E, Vittinghoff E, Colfax G, Gurwith M, et al. Negative social impacts among volunteers in an HIV vaccine efficacy trial. JAcquir Immune Defic Syndr 2007;47:1-7.
35. Buchbinder SP, Metch B, Holte SE, Scheer S, Coletti A, Vittinghoff E. Determinants of Enrollment in a preventive HIV vaccine trial: hypothetical versus actual willingness and barriers to participation. J Acquir Immune Defic Syndr 2004;36:604-12.
36. KoblinBA, Holte S, Lenderking B, Heagerty P. Readiness for HIV vaccine trials: changes in willingness and knowledge among high-risk populations in the HIV network for prevention trials. J Acquir Immune Defic Syndr 2000;24:451-7.
37. Priddy FH, Cheng AC, Salazar LF, Frew PM. Racial and ethnic differences in knowledge and willingness to participate in HIV vaccine trials in an urban population in the Southeastern US. Int J STD AIDS 2006;17:99-102.
38. Crosby RA, Holtgrave DR, Bryant L, Frew PM. Factors associated with the acceptance of an AIDS vaccine: an exploratory study. Prev Med 2004;39:804-8.
39. Salazar LF, Holtgrave DR, Crosby RA, Peterson J, Frew PM. Issues related to gay and bisexual men's acceptance of a future AIDS vaccine. Int J STDs AIDS 2005;16:546-8.
40. Mills E, Wilson K, Rachlis B, Griffith L, Wu P, Guyatt G, et al. Barriers to participation in HIV drug trials: a systematic review. Lancet 2006;6:32-8.
41. Ajzen I, Fishbein M. Understanding attitudes and predicting behavior. Englewood Cliffs, NJ: Prentice-Hall; 1980.
42. Fishbein M, Ajzen I. Belief, attitude, intention, and behavior. Menlo Park, CA: Addison-Wesley; 1975.
43. Meyers LS, Gamst G, Guarino AJ. Applied multivariate research: design and interpretation. Thousand Oaks, CA: Sage Publications; 2006.
44. Allen M, Liang T, Salvia T, Tjugum B, Gulakowski R, Murguia M. Assessing the attitudes, knowledge, and awareness of HIV vaccine research among adults in the United States. J Acquir Immune Defic Syndr 2005;40:617-24.
45. Gregory JR, McNaughton L. Brand logic: a business case for communications. J Adv Res 2004;44:232-6.
46. Miller S, Berry L. Brand Salience Versus Brand Image: Two Theories of Advertising Effectiveness. J Advert Res 1998;38:77-83.
47. Mangini MK. Branding 101: It's time for healthcare to embrace this marketing mainstay. Marketing Health Serv 2002;22:20-3.
48. Moran WT. Brand presence and the perceptual frame. J Adv Res 1990;30:9-15.
49. Zaichkowsky JL. Measuring the involvement construct. J Consumer Res 1985;12:341-52.
50. Shinn E, Basen-Engquist K, Le T, Hansis-Diarte A, Bostic D, Martinez-Cross J, et al. Distress after an abnormal pap smear result: scale development and psychometric validation. Prev Med 2004;39: 404-12.
51. Alexander M, Berger W, Buchholz P, Walt J, Burk C, Lee J, et al. The reliability, validity, and preliminary responsiveness of the Eye Allergy Patient Impact Questionnaire (EAPIQ). Health Qual Life Outcomes 2005;3:1-11.
52. Chang M-W, Brown R, Nizke S. Scale development: factors affecting diet, exercise, and stress management (FADESM). BMC Public Health 2008;8:1-7.
53. Hou S-I, Luh WM. The structure of a web-based HIV testing belief inventory (wHITBI) for college students: the evidence of construct validation. Med Inform Internet Med 2007;32:83-92.
54. Brown TA. Confirmatory factor analysis for applied research. 1st edition. New York, NY: Guilford Press; 2006.
55. Knight GP, Virdin LM, Ocampo KA, Roosa M. An examination of the cross-ethnic equivalence of measures of negative life events and the mental health among Hispanic and Anglo American children. Am J Community Psychol 1994;22:767-83.
56. National Cancer Institute. Clear & simple: developing effective print materials for low-literate readers. Available at: http://www.nci.nih.gov/ cancerinformation/clearandsimple 2003. Accessed January 21, 2009.
57. Kline RB. Principles and practice of structural equation modeling. 2nd edition. New York, NY: Guilford Press; 2005.